Traf2 interacts with Smad4 and regulates BMP signaling pathway in MC3T3-E1 osteoblasts

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 775-779

  Shimada, Koichi ^a   Ikeda, Kyoko ^a   Ito, Koichi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic proteins (BMPs); Osteoblasts; Smad4; TNF receptor associated factor 2 (Traf2); TNF

Indexed keywords

BETA ACTIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; SMAD1 PROTEIN; SMAD4 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ANIMAL CELL; ARTICLE; BMP2 GENE; CELL DIFFERENTIATION; CELL MATURATION; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; DNA LIBRARY; GENE; GENE SILENCING; GENETIC TRANSFECTION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TWO HYBRID SYSTEM; YEAST;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINE; CELL NUCLEUS; GENE SILENCING; MICE; OSTEOBLASTS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

MAMMALIA;

EID: 70449701428     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.048     Document Type: Article

References (31)

1. Lian J.B., Stein G.S., Javed A., van Wijnen A.J., Stein J.L., Montecino M., Hassan M.Q., Gaur T., Lengner C.J., and Young D.W. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev. Endocr. Metab. Disord. 7 (2006) 1-16
2. Miyazawa K., Shinozaki M., Hara T., Furuya T., and Miyazono K. Two major Smad pathways in TGF-β superfamily signaling. Genes Cells 7 (2002) 1191-1204
3. Shi Y., and Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
4. Chen D., Zhao M., and Mundy G.R. Bone morphogenetic proteins. Growth Factors 22 (2004) 233-241
5. Miyazono K., Maeda S., and Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16 (2005) 251-263
6. Shimada K., Suzuki N., Ono Y., Tanaka K., Maeno M., and Ito K. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells. Bone 42 (2008) 886-893
7. Komori T. Regulation of osteoblast differentiation by transcription factors. J. Cell Biochem. 99 (2006) 1233-1239
8. Ducy P., Zhang R., Geoffrov V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
9. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., and Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
10. Shirakabe K., Terasawa K., Miyama K., Shibuya H., and Nishida E. Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5. Gene Cell 6 (2001) 851-856
11. Guo X., and Wang X. Signaling cross-talk between TGF-β/BMP and other pathways. Cell Res. 19 (2009) 71-88
12. Cochran D.L. Inflammation and bone loss in periodontal disease. J. Periodontol. 79 (2008) 1569-1576
13. Srivastava S., Weitzmann M.N., Cenci S., Ross F.P., Adler S., and Pacifici R. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J. Clin. Invest. 104 (1999) 503-513
14. Jilka R.L., Weinstein R.S., Bellido T., Parfitt A.M., and Manolagas S.C. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J. Bone Miner. Res. 13 (1998) 793-802
15. Gilbert L., He X., Farmer P., Rubin J., Drissi H., van Wijnen A.J., Lian J.B., Stein G.S., and Nanes M.S. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2αA) is inhibited by tumor necrosis factor-α. J. Biol. Chem. 277 (2002) 2695-2701
16. Abbas S., Zhang Y.H., Clohisy J.C., and Abu-Amer Y. Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor. Cytokine 22 (2003) 33-41
17. Kaneki H., Guo R., Chen D., Yao Z., Schwarz E.M., Zhang Y.E., Boyce B.F., and Xing L. Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J. Biol. Chem. 281 (2006) 4326-4333
18. Fukunaga E., Inoue Y., Komiya S., Horiguchi K., Goto K., Saitoh M., Miyazawa K., Koinuma D., Hanyu A., and Imamura T. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells. J. Biol. Chem. 283 (2008) 35660-35667
19. Zhang Y., Chang C., Gehling D.J., Hemmati-Brivanlou A., and Derynck R. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc. Natl. Acad. Sci. USA 98 (2001) 974-979
20. Zhu H., Kavsak P., Abdollah S., Wrana J.L., and Thomsen G.H. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400 (1999) 687-693
21. Rothe M., Wong S.C., Henzel W.J., and Goeddel D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78 (1994) 681-692
22. Baker S.J., and Reddy E.P. Modulation of life and death by the TNF receptor superfamily. Oncogene 17 (1998) 3261-3270
23. Rothe M., Sarma V., Dixit V.M., and Goeddel D.V. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269 (1995) 1424-1427
24. Thomas G.S., Zhang L., Blackwell K., and Habelhah H. Phosphorylation of TRAF2 within its RING domain inhibits stress-induced cell death by promoting IKK and suppressing JNK activation. Cancer Res. 69 (2009) 3665-3672
25. Song H.Y., Régnier C.H., Kirschning C.J., Goeddel D.V., and Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94 (1997) 9792-9796
26. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., de la Pompa J.L., Ferrick D., Hum B., Iscove N., Ohashi P., Rothe M., Goddel D.V., and Mak T.W. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7 (1997) 715-725
27. Liu Z.G., Hsu H., Goddel D.V., and Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87 (1996) 565-576
28. Bradley J.R., and Pober J.S. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20 (2001) 6482-6491
29. Carpentier I., Coornaert B., and Beyaert R. Smurf2 is a TRAF2 binding protein that triggers TNF-R2 ubiquitination and TNF-R2-induced JNK activation. Biochem. Biophys. Res. Commun. 374 (2008) 752-757
30. Singhatanadgit W., Salih V., and Olsen I. Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-α in human bone cells. Int. J. Biochem. Cell Biol. 38 (2006) 1794-1807
31. Mukai T., Otsuka F., Otani H., Yamashita M., Takasugi K., Inagaki K., Yamamura M., and Makino H. TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem. Biophys. Res. Commun. 356 (2007) 1004-1010